Skip to main content
. Author manuscript; available in PMC: 2019 May 21.
Published in final edited form as: Prostate. 2010 Oct 1;70(14):1563–1574. doi: 10.1002/pros.21192

Fig. 1.

Fig. 1.

Effects of EGF and Ang II on (A) ATIP and (B) ATIP1 mRNA expression in LNCaP prostate cancer cells and (C) ATIP and (D) ATIP1 mRNA expression in PC3 cells grown to approximately 70% confluence.Values are expressed as % fold difference relative to untreated (control) expression (100%).*,**,*** denote a significant decrease in ATIP mRNA expression in treated compared to untreated cells at P < 0.05, P < 0.01, and P < 0.001, respectively. Statistics were calculated using parametric ANOVAs with Tukey’spost-tests on ΔCt values from seven to nine independent determinations.